QLT CMO steps down

March 1, 2011

Dipak Panigrahi, MD, senior vice president, research and development, and chief medical officer of QLT has stepped down from his position with QLT.

Vancouver, Canada-Dipak Panigrahi, MD, senior vice president, research and development, and chief medical officer of QLT has stepped down from his position.

Suzanne Cadden, QLT’s vice president, Regulatory Affairs, and Anthony Pepio, executive director, Ophthalmology Development have assumed research and development and product portfolio responsibilities. Cadden also assumed overall responsibility for clinical operations at QLT, and Pepio will lead preclinical and formulations development.